Dr. Roman Niedbal, Managing Director / Chief Executive Officer
As CEO Roman is spearheading the further development and expansion of the company’s point-of-care solutions. Together with CFO Sven Klose, he will lead a new business development team actively seeking global strategic partners to open up the diagnostic potential of the pioneering Abviris technology. Roman, who holds a doctorate in microbiology, was previously Vice President Marketing & Medical Innovation at Sysmex Europe where he held various senior management positions for almost ten years. He was also managing director of the Sysmex affiliate, Hitado, which specializes in point-of-care in-vitro diagnostics. Roman previously worked for Human Diagnostics, Biotrin International and Bayer CropScience AG.
Sven Klose, Managing Director / Chief Financial Officer
Before starting his position as managing director at Abviris Sven has led two regional investment funds as well as a pre seed accelerator program. With a track record of eleven years in managing shares and start-up financing he has been a member of various supervisory boards and advisory committees for start-ups such as ImplanData Ophthalmic Products GmbH and smapOne AG. Sven has also founded a start-up company serving as CTO/CFO. At Ernst&Young he gained seven years of experience in the role of Senior Risk Consultant and in year-end audits. Sven holds a diploma in industrial engineering and management from Hamburg University.